3–12 day dispatch window due to updated U.S. documentation requirements • All tariff costs covered
Showing all 2 results
Various botulinum toxin type A formulations have become a cornerstone of both aesthetic and therapeutic medicine worldwide. Among the modern neuromodulators developed in South Korea, Innotox has gained significant attention due to its innovative liquid formulation, reliable performance, and growing global adoption. Developed with advanced biotechnology and strict quality standards, Innotox is increasingly chosen by healthcare professionals for a wide range of cosmetic and medical procedures.
Below you will find detailed information about the Innotox brand, including its manufacturer, formulation features, mechanism of action, clinical indications, contraindications, expected treatment results, safety profile, and key advantages.
WORTH KNOWING:
Innotox is praised for its predictable results, safety, and natural-looking outcomes by many patients and practitioners.
Innotox is an advanced botulinum toxin type A injectable developed by Medytox Inc., a biotechnology company headquartered in South Korea that specializes in the research, development, and manufacturing of botulinum toxin products and other biologics. Since its founding, Medytox has played a prominent role in the global neuromodulator market.
The company operates modern manufacturing facilities that comply with strict Good Manufacturing Practice (GMP) regulations. Medytox places strong emphasis on:
Through continuous research initiatives and clinical development programs, Medytox has positioned Innotox as an innovative botulinum toxin type A product within the expanding global aesthetic medicine sector.
The international market for botulinum toxin products includes several well-established brands with different formulations and manufacturing technologies, such as Botox, Dysport, Xeomin, and so on. Innotox distinguishes itself by introducing a liquid botulinum toxin preparation that eliminates the need for reconstitution prior to injection and does not include animal-derived proteins.
The product reflects South Korea’s strong role in shaping global aesthetic treatment trends, particularly in minimally invasive facial procedures.
As demand for neuromodulators continues to grow worldwide, clinicians typically assess botulinum toxin products based on:
Within this competitive environment, Innotox continues to strengthen its presence in international markets as a modern alternative to traditional lyophilized botulinum toxin products.
WORTH KNOWING:
Innotox is free from human serum albumin and animal-derived proteins, minimizing allergy risks compared to some other botulinum toxins. Also, clinical studies show that Innotox delivers comparable wrinkle reduction with a faster onset and longer duration than traditional botulinum toxins.
The primary active ingredient in Innotox is purified botulinum toxin type A derived from Clostridium botulinum. Unlike many other neuromodulators, Innotox is supplied as a stable liquid solution rather than a freeze-dried powder.
Its formulation includes botulinum toxin type A along with stabilizing components such as L-methionine, polysorbate 20, and sodium succinate. The liquid preparation allows the product to be injected directly without dilution.
WORTH KNOWING:
Innotox has a precise concentration of 4 U/0.1 mL, ensuring consistent results across treatment areas.
Key formulation properties include:
It is important to understand that botulinum toxin units are determined using manufacturer-specific biological assays. Therefore, the dosing units of Innotox are not directly interchangeable with units used for other botulinum toxin brands.
Innotox is typically distributed in the following vial presentations:
WORTH KNOWING:
…
Innotox produces its clinical effect through the same neuromodulatory pathway as other botulinum toxin type A formulations by blocking neuromuscular transmission in targeted muscles.
This mechanism includes several biological stages:
By preventing acetylcholine release, nerve signals that normally trigger muscle contraction are blocked. The treated muscle therefore relaxes, leading to a reduction in dynamic wrinkles or excessive muscle activity.
Over time, the affected nerve endings regenerate functional synaptic connections, gradually restoring normal muscle function.
WORTH KNOWING:
…
In cosmetic medicine, Innotox Innotox is primarily indicated for temporary improvement in the appearance of moderate to severe dynamic facial wrinkles caused by repetitive muscle activity. Common aesthetic treatment areas include:
Additionally, precise injections into selected muscles can produce optimal results when it comes to subtle lifting effects in the brow region, contributing to a refreshed facial appearance.
When administered by experienced practitioners, Innotox can provide consistent results and natural-looking outcomes while maintaining normal facial expressiveness.
Beyond facial rejuvenation through the creation of smoother skin and improvement of facial harmony, the ability of Innotox to cause temporary muscle weakness may also be used in various therapeutic contexts depending on regulatory approvals and clinical practice guidelines.
As clinical studies show, medical conditions that may be treated with botulinum toxin type A include:
In these settings, the neuromodulatory action of botulinum toxin helps reduce abnormal muscle contractions or excessive glandular activity, improving functional outcomes and patient comfort.
Healthcare professionals must always follow regional regulatory approvals and product labeling when determining treatment indications.
WORTH KNOWING:
Innotox is primarily indicated for temporary improvement in the appearance of moderate to severe dynamic facial wrinkles caused by repetitive muscle activity. However, it is more and more frequently used to take care of medical problems associated with muscle contraction.
Clinical observations indicate that Innotox provides predictable treatment outcomes in both aesthetic and therapeutic applications. Most patients begin to notice visible effects within approximately 2-5 days (in most cases, up to one week) following injection.
Maximum improvement is typically reached within 7-14 days, when the neuromuscular blockade becomes fully established. Commonly, the duration of action after the procedure lasts between three and four months, although individual results may vary depending on factors such as treatment zone, injected dose, frequency of previous treatments., and patient metabolism and muscle strength.
With repeated procedures and precise targeting of particular muscles, some patients may experience longer-lasting results due to gradual reduction in muscle activity. To maintain results, most patients schedule maintenance treatments every three to six months.
WORTH KNOWING:
According to many healthcare providers, Innotox’s effects typically last between three and eight months, depending on individual factors.
When administered according to recommended protocols, the ready-made solution of Innotox is generally considered safe and well tolerated. However, as with any botulinum toxin product, certain adverse reactions may occur.
Common reactions to Innotox are usually mild and resolve within a short period. They include:
These reactions are usually mild and resolve spontaneously within a few days.
In rare cases, more serious adverse reactions might appear. Less frequent side effects may include eyelid drooping (ptosis), brow asymmetry, blurred vision, swallowing difficulties in cervical treatments, or mild flu-like symptoms. Rare but serious complications may involve breathing difficulties or symptoms resembling botulism.
Although uncommon, systemic spread of the toxin effect may lead to generalized muscle weakness or respiratory problems. For this reason, careful patient evaluation and proper injection technique are essential.
WORTH KNOWING:
Botulinum toxin is a potent neurotoxin, and injections by unlicensed individuals can lead to severe complications like muscle paralysis and difficulty breathing.
Non-surgical procedures that involve Innotox injections should not be administered under the following conditions:
Before treatment, healthcare professionals should perform a thorough patient assessment and review medical history to minimize potential risks.
WORTH KNOWING:
Prior to administration, thorough assessment and consultation must be conducted to determine the most suitable injection sites and dosage for optimal results. Also, patients should disclose their full medical history and any medications they are taking before scheduling Innotox injections to ensure safety and efficacy.
Innotox offers several advantages that make it appealing to medical practitioners.
Unlike many botulinum toxin products that require reconstitution, Innotox is supplied in a finished liquid phase which is ready to use, simplifying preparation and reducing potential dilution errors. The purified botulinum formulation of Innotox is rigorously tested for potency, sterility, and stability.
Innotox is an advanced botulinum toxin type A injectable developed by Medytox Inc., known for its high efficacy and excellent safety profile. When administered properly, Innotox injections deliver consistent neuromodulatory effects and predictable aesthetic outcomes, such as a more youthful facial appearance.
Innotox works by relaxing targeted facial muscles responsible for expression lines and wrinkles. Injectable treatments involving Innotox are typically quick, involve minimal downtime, and can be performed in outpatient medical settings. They also minimize allergic reactions and complications. The procedure involves injecting small amounts of Innotox into specific facial muscles using fine needles.
Patients often report high levels of satisfaction due to visible improvements in facial wrinkles through Innotox injections in specific facial muscles or relief from medical symptoms. Namely, Innotox effectively addresses dynamic facial wrinkles, such as forehead lines and crow’s feet, providing comprehensive rejuvenation and facial contouring benefits. The effects of Innotox injections typically last between three and eight months, depending on factors such as patient metabolism and lifestyle.
As Korean aesthetic medicine continues to influence global practice, Innotox is gaining increasing recognition among clinicians and patients worldwide, all thanks to its high product integrity and amazing results.
Innotox is an innovative botulinum toxin type A product developed by Medytox Inc., distinguished by its ready-to-use liquid formulation and consistent clinical performance. Its neuromodulatory mechanism, versatility across aesthetic and therapeutic indications, and predictable outcomes make it a valuable option for qualified healthcare professionals treating dynamic wrinkles and neuromuscular conditions.
If you are a licensed medical professional searching for a reliable supplier of Innotox products, FillerSupplies offers a broad selection of professional botulinum toxin solutions available for purchase. Here, you will be able to take advantage of beneficial wholesale pricing and fast shipping. So, place your order today!
WORTH KNOWING:
Innotox is primarily marketed to medical professionals and typically requires buyers to be licensed healthcare providers for procurement. Licensed healthcare professionals can obtain Innotox only through authorized medical distributors to ensure safety and authenticity. When buying Innotox online, it is essential to verify that the supplier is certified and reputable.
You may download the form, complete it and email back to [email protected].
Or fax it at 360.768.3126